NCT01262586已完成3 期
Pilot Study to Assess the Difference in Glycemic Profiles Between Vildagliptin and Glimepiride Using Continuous Glucose Monitoring Device
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Change in Glycemic profiles between vildagliptin and glimepiride
研究概览
简要总结
This study will use Continuous Glucose Monitoring to assess differences in glycemic profiles between vildagliptin and glimepiride.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Type 2 diabetes patients on stable metformin
- •18-70 years old
- •Willing to perform at least 4 capillary blood glucose tests per day
排除标准
- •Type 2 diabetes patients on any other antidiabetic treatment
- •Patients listed in other trials
- •Patients with significant diabetic organ disease or complications.
- •Other protocol-defined inclusion/exclusion criteria may apply
研究组 & 干预措施
Vildagliptin
Experimental
干预措施: Vildagliptin (Drug)
Glimepiride
Active Comparator
干预措施: Glimepiride (Drug)
结局指标
主要结局
Change in Glycemic profiles between vildagliptin and glimepiride
时间窗: Baseline and treatment Day 5, 24hr continuous glucose measurements
次要结局
- Glucose Fluctuation before and during treatment(Baseline and treatment Day 5, 24hr continuous measurements)
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Pilot study to assess the difference in glycemic profiles between vildagliptin and glimepiride using CGM deviceEUCTR2010-021236-34-DEovartis Pharma Services AG
已完成
不适用
Determining variation in glucose levels in people with impaired glucose tolerance (prediabetes)Impaired glucose toleranceNutritional, Metabolic, EndocrineAbnormal glucose tolerance testISRCTN15304729Abbott Diabetes Care Ltd43
已完成
不适用
Continuous Glucose Monitoring During Diets That Differ in Glycemic LoadGlucose Metabolism DisordersNCT02926118Unilever R&D23
已完成
4 期
Toujeo Versus NPH Self-titration StudyDiabetes Mellitus, Type 2NCT03389490Elaine Chow50
已完成
不适用
The Effect and Safety of a Novel CGM-Based Titration Algorithm for Basal Insulin in T2DM Participants.Type 2 DiabetesNCT06111508University of Virginia30